Literature DB >> 12411588

Template-directed dye-terminator incorporation with fluorescence polarization detection for analysis of single nucleotide polymorphisms implicated in sepsis.

Bradley D Freeman1, Timothy G Buchman, Sean McGrath, Arash Rafii Tabrizi, Barbara A Zehnbauer.   

Abstract

Sepsis continues to be a common source of morbidity and mortality in critically ill patients. Single nucleotide polymorphisms (SNPs) present in genes encoding inflammatory mediators have been associated with predisposition and outcome in this syndrome. The use of high throughput SNP analysis in large epidemiological studies is necessary to more fully understand the genetic underpinnings of this disease. We adapted template-directed dye-terminator incorporation with fluorescence polarization detection (TDI-FP) to the analysis of eight SNPs implicated in mediating the sepsis syndrome: TNF-alpha (-308), TNF-alpha (-238), TNF-beta (+250), IL-1beta (+3953), IL-6 (-174), IL-10 (-592), plasminogen activator inhibitor-1 (PAI-1 (-675)), and TLR4 299 (+1032). Optimization of PCR, amplicon purification, and template-directed dye-terminator incorporation reactions were necessary to achieve acceptable performance characteristics for these assays. Sequence validated samples served as controls. Using this method we were able to assign genotype in 99.3% of assays and identified 64 unique genotypes in samples obtained from 90 individuals. TDI-FP is a flexible and robust method of SNP detection that can be optimized in a systematic fashion. This method has potential advantages compared with other high throughput genotyping techniques and appears well suited to clinical situations requiring analysis of large numbers of samples.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411588      PMCID: PMC1907358          DOI: 10.1016/S1525-1578(10)60705-2

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  26 in total

1.  Induced heteroduplex genotyping of TNF-alpha, IL-1beta, IL-6 and IL-10 polymorphisms associated with transcriptional regulation.

Authors:  H R Morse; O O Olomolaiye; N A Wood; L J Keen; J L Bidwell
Journal:  Cytokine       Date:  1999-10       Impact factor: 3.861

2.  Genetic factors in septic shock.

Authors:  A Kumar; J Short; J E Parrillo
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

Review 3.  Genetic markers in sepsis.

Authors:  A R Tabrizi; B A Zehnbauer; B D Freeman; T G Buchman
Journal:  J Am Coll Surg       Date:  2001-01       Impact factor: 6.113

4.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.

Authors:  N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

5.  Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.

Authors:  J P Mira; A Cariou; F Grall; C Delclaux; M R Losser; F Heshmati; C Cheval; M Monchi; J L Teboul; F Riché; G Leleu; L Arbibe; A Mignon; M Delpech; J F Dhainaut
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

6.  Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma.

Authors:  C Zheng; D R Huang; S Bergenbrant; A Sundblad; A Osterborg; M Björkholm; G Holm; Q Yi
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

7.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.

Authors:  P W Hermans; M L Hibberd; R Booy; O Daramola; J A Hazelzet; R de Groot; M Levin
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

8.  Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.

Authors:  R G Westendorp; J J Hottenga; P E Slagboom
Journal:  Lancet       Date:  1999-08-14       Impact factor: 79.321

Review 9.  Anti-inflammatory therapies in sepsis and septic shock.

Authors:  B D Freeman; C Natanson
Journal:  Expert Opin Investig Drugs       Date:  2000-07       Impact factor: 6.206

10.  Tumor necrosis factor gene polymorphism and septic shock in surgical infection.

Authors:  G J Tang; S L Huang; H W Yien; W S Chen; C W Chi; C W Wu; W Y Lui; J H Chiu; T Y Lee
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

View more
  1 in total

1.  Differentiation of Erwinia amylovora and Erwinia pyrifoliae strains with single nucleotide polymorphisms and by synthesis of dihydrophenylalanine.

Authors:  I Gehring; K Geider
Journal:  Curr Microbiol       Date:  2012-04-27       Impact factor: 2.188

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.